New nanotechnology will allow detection of blocked arteries more effectively than ever before
Heart disease and stroke are the world’s two most deadly diseases, causing over 15 million deaths in 2016 according to the World Health Organization. A key underlying factor in both of these global health crises is the common condition, atherosclerosis, or the build-up of fatty deposits, inflammation and plaque on the walls of blood vessels. By the age of 40, around half of us will have this condition, many without symptoms.
A new nanoparticle innovation from researchers in USC Viterbi’s Department of Biomedical Engineering may allow doctors to pinpoint when plaque becomes dangerous by detecting unstable calcifications that can trigger heart attacks and strokes.
The research — from Ph.D. student Deborah Chin under the supervision of Eun Ji Chung, the Dr. Karl Jacob Jr. and Karl Jacob III Early-Career Chair, in collaboration with Gregory Magee, assistant professor of clinical surgery from Keck School of Medicine of USC — was recently published in the Royal Society of Chemistry’s Journal of Materials Chemistry B on 25 September 2019.
When atherosclerosis occurs in coronary arteries, blockages due to plaque or calcification-induced ruptures can lead to a clot, cutting blood flow to the heart, which is the cause of most heart attacks. When the condition occurs in the vessels leading to the brain, it can cause a stroke.
“An artery doesn’t need to be 80 percent blocked to be dangerous. An artery with 45% blockage by plaques could be more rupture-prone,” Chung said. “Just because it’s a big plaque doesn’t necessarily mean it’s an unstable plaque.”
Chung said that when small calcium deposits, called microcalcifications, form within arterial plaques, the plaque can become rupture prone.
However, identifying whether blood vessel calcification is unstable and likely to rupture is particularly difficult using traditional CT and MRI scanning methods, or angiography, which has other risks.
“Angiography requires the use of catheters that are invasive and have inherent risks of tissue damage,” said Chin, the lead author. “CT scans on the other hand, involve ionizing radiation which can cause other detrimental effects to tissue.”
Chung said that the resolution limitations of traditional imaging offers doctors a “bird’s eye view” of larger-sized calcification, which may not necessarily be dangerous. “If the calcification is on the micro scale, it can be harder to pick out,” she said.
The research team developed a nanoparticle, known as a micelle, which attaches itself and lights up calcification to make it easier for smaller blockages that are prone to rupture to be seen during imaging.
Chin said the micelles are able to specifically target hydroxyapatite, a unique form of calcium present in arteries and atherosclerotic plaques.
“Our micelle nanoparticles demonstrate minimal toxicity to cells and tissue and are highly specific to hydroxyapatite calcifications,” Chin said. “Thus, this minimizes the uncertainty in identifying harmful vascular calcifications.”
The team has tested their nanoparticle on calcified cells in a dish, within a mouse model of atherosclerosis, as well as using patient-derived artery samples provided by vascular surgeon, Magee, which shows their applicability not only in small animals but in human tissues.
“In our case, we demonstrated that our nanoparticle binds to calcification in the most commonly used mouse model for atherosclerosis and also works in calcified vascular tissue derived from patients,” Chin said.
Chung said that the next step for the team was to harness the micelle particles to be used in targeted drug therapy to treat calcification in arteries, rather than just as means of detecting the potential blockages.
“The idea behind nanoparticles and nanomedicine is that it can be a carrier like the Amazon carrier system, shuttling drugs right to a specific address or location in the body, and not to places that you don’t want it to go to,” Chung said.
“Hopefully that can allow for lower dosages, but high efficacy at the disease site without hurting normal cells and organ processes,” she said.
Learn more: Lighting Up Cardiovascular Problems Using Nanoparticles
Go deeper with Bing News on:
Atherosclerosis
- World Hypertension Day: How hypertension leads to other diseases and why it is important to have regular health check up
Hypertension damages blood vessels, leading to atherosclerosis and plaque buildup, affecting the heart with cardiac hypertrophy and increasing the risk of heart failure. It also impacts the kidneys, ...
- Global initiative REACT targets early detection of atherosclerosis
One in three people around the world die from cardiovascular disease, which is mainly caused by atherosclerosis. This makes atherosclerosis the leading cause of death globally. Additionally, many ...
- One in three people die due to atherosclerosis: A new initiative aims to find new ways to prevent it
Globally, cardiovascular diseases due to atherosclerosis – the build-up of plaque in arteries – are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to ...
- New guideline focuses on early diagnosis, targeted treatment of peripheral artery disease
A newly released guideline from the American Heart Association and the American College of Cardiology gives clinicians details on how to treat people with lower extremity peripheral artery disease ...
- Atherosclerosis News and Research
Columbia University researchers have found cells inside clogged arteries share similarities with cancer and aggravate atherosclerosis, raising the possibility that anticancer drugs could be used ...
Go deeper with Google Headlines on:
Atherosclerosis
[google_news title=”” keyword=”atherosclerosis” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Micelle nanoparticles
- FDA Grants Fast Track Designation to SNB-101 in SCLC
SNB-101, a nanoparticle drug for small cell lung cancer, received a fast track designation from the FDA for expedited development and review.
- SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer ...
- Stimulus-responsive Macromolecules and Nanoparticles for Cancer Drug Delivery
Macromolecular carriers and nanoparticle vehicles enhance the circulation, accumulation and efficacy of chemotherapeutics. Thermally responsive peptide polymers improve tumor accumulation by ...
- Nanotechnology in Therapeutics
Nanomedicine. 2012;7(8):1253-1271. Liposomes Liposomes are self-assembled artificial vesicles developed from amphiphilic phospholipids. These vesicles consist of a spherical bilayer structure ...
- Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl
Star's sensor uses carbon nanotubes and gold nanoparticles to tell fentanyl apart from other opioids. The key to its groundbreaking sensitivity, however, is the incorporation of fentanyl antibodies.
Go deeper with Google Headlines on:
Micelle nanoparticles
[google_news title=”” keyword=”micelle nanoparticles” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]